HOME
|
SITE MAP
|
CONTACT US
|
PARTNERS
R & D
Pipeline
Bepreve™
Xibrom™
Istalol
®
Vitrase
®
Xibrom XiDay
(once-daily)
Bromfenac
Low-Dose for Dry Eye
Bepotastine
Nasal Spray
Ecabet Sodium
T-Pred™
ISTA is developing a strong product pipeline to fuel future growth, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S.
To read about the ISTA product pipeline, please
click here
.
© 2009 ISTA Pharmaceuticals. All Rights Reserved.
Disclaimer
|
Privacy Policy
Executive
Management
Board of Directors
Quarterly Fact Sheet
Bepreve
TM
Xibrom
TM
Vitrase
®
(hyaluronidase injection)
Ovine 200 USP Units/mL
Istalol
®
Glaucoma
Links
Corporate Governance
Stock Information
SEC Filings
Fundamentals
Press Releases
Event Calendar
Recent Investor
Presentations and
Audio Archives
Annual Reports
Analyst Coverage
Estimates
Info Requests
Email Alerts
Management
Board of Directors
Committee
Composition
Conduct
Insider Transactions
Pipeline
Bepreve
TM
Xibrom
TM
Istalol
®
Vitrase
®
Xibrom XiDay
™
Bromfenac
Low-Dose for Dry Eye
Bepotastine
Nasal Spray
Ecabet Sodium
T-Pred
TM